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Abstract  
Targeted radiotherapy is proving to be an effective alternative to external beam radiotherapy 
for cancer treatment. Gold nanoparticles are bio-compatible, commercially available and 
readily functionalised, which makes them perfect candidates for the delivery of cytotoxic 
radionuclides labelled with antibodies to proteins abnormally expressed on cancer tissue. 
However, there is a lack of information regarding the efficacy of the successive modification 
steps involved in the functionalisation process, as well as of the actual final state of the 
nanoparticles prior to preclinical tests, which results in a very inefficient screening and that 
will further impact on biological barriers, such as half-life interactions with serum proteins. 
Here, gold nanoparticles (15 nm diameter) were functionalised with linkers for antibody and 
radionuclide conjugation, following a well-stablished method. Successful coating of the gold 
nanoparticles was demonstrated using state-of-the-art physico-chemical techniques, which 
include TEM, AF4-UV-ICPMS-MALS, Raman spectroscopy and force-distance spectroscopy, 
which have led to an accurate description of the hydrodynamic diameter of the functionalized 
NPs and also about the adhesion energy and elastic properties of the modified NPs. Successive 
steps involved in the coating led to an organic shell of 12 nm diameter and no nanoparticle 
aggregation was observed. This may be a consequence of a decrease (or even the total absence) 
of water adsorption on the metal surface and/or of the organic labelling, that decreases the 
surface tension of the particles as estimated from the atomic force microscopy force-distance 
curves. Radiolabelling of gold nanoparticles pre-screened using these physico-chemical tools 
with 177Lu resulted in > 75% efficiency. 
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1. Introduction 
Radiotherapy is highly effective at sterilising cancer stem cells,1 which represent about 1 in 
1000 cancer cells in a malignancy and are responsible for tumour repopulation, development 
and recurrence.2 Radiotherapy induces cellular macromolecular damage e.g. to DNA by 
interacting either directly with the macromolecule or by producing free radicals, such as 
hydroxyl radicals formed from water, which react with and induce chemical changes in the 
macromolecule. The lethal effect of radiotherapy is generally considered to result from DNA 
damage. Irradiation of Au nanoparticles (NPs) can induce inner shell ionisations of the Au 
atoms and subsequent emission of Auger electrons, which enhance the radiation cytotoxic 
effect 3. Consequently, Au NPs, which demonstrate selective retention by cancer cells, have 
been employed as radio-sensitizers in radiotherapy.3  
More recently, Au NPs have been used as radiation delivery systems by surface modification 
with chelators bearing β-emitting radionuclides and targeted to cell surface receptors using a 
range of targeting moieties.6,12,13 These include antibodies to the epidermal growth factor 
receptor (EGFR), which is overexpressed in several cancer types including the treatment-
refractory triple-negative breast cancer. This cancer treatment approach is known as targeted 
radiotherapy (TR), can be considered an example of precision medicine and unlike external 
beam radiotherapy, it delivers a radiation dose to the primary tumour and secondary metastatic 
spread which similarly over-express cell surface proteins. Low-energy β-particle emitters, such 
as 177Lu, deliver their radiation dose within a short-range (1-2 mm) so, when targeted to cancer 
cells, will deposit most of their dose within the tumour, sparing surrounding non-tumour 
tissues. There are many types of biocompatible nanomaterials that can be modified to carry 
radionuclides, such as dendrimers,4-5 but are also heat labile and cannot withstand the high 
radiolabelling temperatures required for chelation of 177Lu. Au NPs are non-toxic, 
biocompatible and can be readily functionalized using bifunctional PEG linkers with thiol 
groups at one end that readily bind to Au producing highly stable Au-S bonds. The other end 
of the linker can be modified by conjugation with a chelator or with a chemical group that can 
be used to conjugate with a targeting moiety e.g. SVA (succinimidyl valeric acid), which is 
readily reacted with amino groups present in antibodies (AB). The 1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-type chelating agents have been 
extensively used, since they show high labelling efficiency with 177Lu and high complex 
stability,6-8 which has been demonstrated to play an important role in the performance of the 
conjugates.7-8 Further, since cytotoxic effects of these compounds are dependent on the amount 
of radioactivity they carry, an approach that optimises the radiolabelling efficiency also leading 
to a better understanding of the chemical nature of functionalised Au NPs is crucial to progress 
this approach to cancer treatment. A detailed characterization of all steps involved in the 
functionalization process is a remaining goal to ensure compound optimisation, aimed at 
overcoming associated obstacles related to toxicity 9, dose control and tumour penetration in 
poorly vascularized regions as well as simplifying the labelling process. 
Within this aim, we have methodically examined the assembly of Au NPs, based on a 
modification of a previously described radiolabelling method.10-12 The modifications, include 
the use of smaller, 15 nm Au NPs as carriers of 177Lu tagged with an anti-EGFR antibody (AB) 
as the targeting moiety that can bind to EGFR-overexpressing primary and metastatic cancer 
cells. A further modification is the radio-labelling of the chelator after attachment to the Au 
NPs, which is considered to be advantageous7 over pre-Au NP-conjugation radiolabelling. 
Using state-of-the-art physico-chemical techniques, we have obtained an accurate description 
of: (i) the size of fully-functionalised particles, using multidetector analysis asymmetrical flow 
field-flow fractionation (AF4); and (ii) the adhesion energy and elastic properties of the 
modified NPs, by force distance spectroscopy (FDS) and atomic force microscopy (AFM) 
imaging. Particle size is a critical parameter for nanostructured materials for biomedical 
applications. Multidetector-coupled AF4 has arisen as a promising technique for this purpose13-
17, where other routine characterization techniques, such as scanning and transmission electron 
microscopy (SEM and TEM, respectively) and dynamic light scattering (DLS), fail.18-21 
Unfractionated DLS, at best, differentiates particles that vary in size by a factor of 3 to 5, 
whereas AF4-MALS is capable of resolving accurately particles that vary in size by just a few 
percent, and additionally helps in the determination of shape. MALS detector is unaffected by 
aggregation, adsorption and sedimentation of particles, which are limitations associated with 
DLS. It also offers a vertical flow cell where the sample can pass through easily without any 
obstacles in its way. While DLS measures at a single scattering angle of 173°, MALS detector 
employs 21 angles, from 7° to 164°, ensuring accuracy and precision in particle size 
determination when measuring complex particular samples. In addition, MALS detector can 
measure NP radius of gyration in the range of 8 nm to 500 nm, depending on the sample. 
Besides, AFM in the imaging mode has been extensively used for characterisation of 
nanoparticle shape and/size22-24 and, in recent years, its application in biological samples has 
exponentially increased due to the development of single-molecule force spectroscopy with 
chemically modified AFM probes.25-28 However, despite the versatility of this technique, little 
attention has been paid to the characterization of nanoparticles adhesion energy by FDS.29-32 
Accordingly, we have examined the NPs adhesion energy in every step of the coating process, 
which has led us to elaborate a construction sequence for direct radiolabelling.  
To the best of our knowledge, the combination of these physico-chemical techniques has not 
been used before, even though they have shown to provide reliable information of the 
sequential functionalisation of NPs. Our experiments integrate knowledge in the areas of 
materials, physics, bioscience, and chemistry for the adequate characterization of radionuclide 
carriers in order to improve cell uptake. The provided information is suggested to lead to the 
development of more efficient architectures of tagged NPs for radio- and chemotherapy 
treatments. 
 
 
2. Materials and methods 
2.1 Reagents and materials 
Ortho-pyridyl disulphide-polyethyleneglycol-succinimidyl valeric acid (OPSS-PEG-SVA, 
MW 5000) and OPSS-PEG3500-amine were purchased from Laysan Bio (AL, USA) and 
JemKem Technology (TX, USA), respectively. Non-coated gold NPs (15 nm) in 0.1 mM 
phosphate buffered saline (PBS) were purchased from Stratech (Suffolk, UK). Erbitux (Merck 
Serono Ltd) was purchased from AAH Pharmaceuticals (UK) and a weighed amount (typically 
10 mg of lyophilisate dissolved in 0.5 mL of H2O) purified on a centrifugal filter (Sigma-
Aldrich, UK) with a 30 KDa cut off. The concentration of Erbitux recovered from the filter 
was determined using the extinction coefficient of 1.4 for 1 mg mL-1 at 280 nm after measuring 
absorbance at 280 nm using a spectrophotometer (Thermo Spectronic Helios γ). [177Lu]LuCl3 
was purchased from Perkin-Elmer (Beaconsfield, UK) in doses of 370 MBq. All other 
chemicals were purchased from Sigma-Aldrich (Poole, UK) unless otherwise stated.  
2.2 Experimental 
Preparation of OPSS-PEG-DOTA. Linkers with the OPSS (Ortho-pyridyl disulphide) 
functionality are commonly utilised to provide binding to gold surfaces exploiting the strength 
of the Au-S bond.33 PEG (polyethylene glycol) coating of particle surfaces serves to enable 
evasion of the immune system by preventing their opsonisation (surface tagging of foreign 
substances in the body to expedite their removal by phagocytic cells).34-36 Surface coating is 
also essential in preventing NP aggregation. DOTA is a strong chelator of Lu facilitating the 
linking of 177Lu to the NP.10, 37 
100 mg of DOTA was dissolved in 0.625 mL of 5 M NaOH. The pH was adjusted to 8.5 by 
addition of HCl. 15 mg of 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl morpholinium 
chloride (DMTMM) were dissolved in 100 µL of H2O and mixed for 5 min, followed by 
addition of 30 mg OPSS-PEG-NH2 dissolved in 100 L of H2O for 1 h. The mixture was then 
placed in a 1 kDa cut off dialysis capsule (Sigma-Aldrich) and the capsule was placed in 200 
mL of water, which was changed 3 times daily for 3 days. The volume capsule was then 
removed from the water and the contents dried by placing them in a stream of air. The OPSS-
PEG-DOTA was then suspended in H2O or D2O for 
1H-NMR analysis.  
Functionalisation of Au NPs with linkers. 1 mL of Au NPs (containing ca. 1.64 x 1012 particles) 
were centrifuged at 20000 g for 30 min and all but about 25 µL the supernatant removed.  
OPSS-PEG-SVA (20 µg) and OPSS-PEG-DOTA (50 µg) were premixed in a total volume of 
10µL, mixed with the concentrated NPs and left overnight at room temperature, after which 10 
µg of PEG-thiol (PEG-SH) was added and incubated for a further 1 h. After addition of 1mL 
of H2O, the functionalised NPs were centrifuged at 20000 g for 30 min. This was repeated to 
remove all non-bound linkers and the NPs suspended in 25 µL of H2O.   
Radiolabelling of NPs with [177Lu]LuCl3 and targeting with AB. Au NPs functionalised as 
described above were mixed with 10 µL of 0.5 M citrate buffer and 20 MBq of [177Lu]LuCl3 
then placed in a heating block and heated at 80 oC for 20 min. Non-chelated [177Lu]LuCl3 was 
removed by centrifugation after addition of 1 mL of H2O. Labelling efficiency was determined 
by measuring activity in the washes and in the washed NPs by scintillation counting of diluted 
(1:2000) samples. The radiolabelled NPs were then suspended in 50 µL of 0.1M NaHCO3 
containing 200 µg of Erbitux and incubated overnight at room temperature. The radiolabelled 
and Erbitux-tagged NPs (which from now on we will design as targeted 177Lu-AB-labelled 
NPs) were suspended in 1 mL of PBS and centrifuged as described. This step was carried out 
twice and the NPs finally suspended in 100 µL of PBS. They were then sterile filtered through 
a centrifugal 0.22 µm filter by centrifuging at 4000 g for 2 min. NP aggregation was not a 
problem but we did encounter irreversible attachment of the fully functionalised nanoparticles 
to the microfuge tube during the washing centrifugations after incubation with AB. However, 
this was remedied by centrifuging the tagged NPs in 10 mM NaHCO3 (pH 8.5). AB-tagged Au 
NPs functionalised with OPSS-PEG-DOTA were incubated for 20 min at 80 oC with 10 MBq 
[177Lu]LuCl3, after which 1 mL of water was added. NPs were then pelleted by centrifugation, 
washed with a further 1 mL of water and centrifuged again. Radioactivity in the supernatants 
and pellet were measured in a well counter. Radiolabelling efficiency was the activity in the 
washed pellet as a percentage of the total activity and achieved on average > 75%.  The 
preparation was found to be stable for 24 h at room temperature (98% (±2) n=5) and up to 5 
days (95% (±2) n=2) at 4oC.  
Determination of EGFR expression. EGFR expression was determined using an ELISA assay 
kit (Fisher Scientific UK) following the manufacturer’s (Invitrogen Thermo-Fisher Scientific) 
instructions. 
2.3 Instrumentation 
TEM images were acquired with a JEM-1400 Plus transmission electron microscope (JEOL, 
Japan) operated at 120 kV. 
Asymmetric flow field flow fractionation coupled with UV absorption, multi angle light 
scattering (MALS) and inductively coupled plasma mass spectrometry (ICPMS) detection 
(AF4-UV-MALS-ICPMS) measurements were performed with an AF2000 MT FFF (Postnova 
Analytics, GmbH) and 8800 Triple Quadrupole ICP-MS/MS (Agilent, USA). The AF4 multi-
flow separation system was equipped with a PN7520 solvent degasser, PN5300 auto-sampler, 
2 isocratic pumps (PN1150) for injection and focus flows, and two Kloehn syringe pumps for 
generation of cross flow. Its trapezoid separation channel (PN4020, Postnova Analytics) had 
dimensions of 335 x 60 x 40 mm, and internal thickness of 350 µm, fitted with a regenerated 
cellulose acetate filter membrane (MWCO = 10 kDa, Postnova Analytics, GmbH). The 
UV/vis-detector (PN3211) spectral range was 190 nm – 700 nm. The MALS detector had 21 
scattering angles ranging from 7˚ to 164˚, with that of 90˚ showing the most intense peak. The 
Nova AF2000 FFF Analysis software was used for the study of MALS results. A PN9050 
ICPMS interface enabled online connection of the AF4 outflow to the ICPMS detector. Milli-
Q water (Millipore Purification System, 18 MΩ cm) was used as mobile phase/eluent in all 
cases. Sample volume injections were typically of 20 µL under a 0.5 mL min-1 flow rate, and 
the channel was rinsed with water for 3 min between each sample injection to avoid memory 
effects (specific elution conditions are shown in Table S1 in the Supporting Information). 
ICPMS was operated with a RF power (1550 MW), 0.79 L min-1 carrier gas, 2.8 mL min-1 H2 
as collision gas and spray chamber temperature of 2 ˚C. Data was acquired in the time resolved 
analysis (TRA) mode at 0.3 sec acquisition time. 
All Raman experiments were performed using an inVia High Resolution Confocal Raman 
Spectrometer (Renishaw plc, Wotton-under-edge, UK). The excitation line at 785 nm was 
provided by an NIR diode laser (max. 300 mW) and 1200 lines/mm spectrographic grating. A 
50x objective for laser illumination and scattered light collection was used with a theoretical 
spot diameter of 1.7 m.  
Atomic force microscopy (AFM) measurements were performed with a NanoObserver AFM 
microscope (CS Instruments, France), using silicon nitride cantilevers from APPNANO (SPM 
probe Fort: f = 200-400 kHz; k = 13-77 N m-1). It is worth noting that the spring constant of the 
cantilever was calculated from the average dimensions of the cantilever provided by the 
manufacturer. Samples were deposited on muscovite mica substrates from Agar Scientific. 
Ultima GoldTM (Perkin Elmer, UK) on a Packard Tri-Carb 2100TR scintillation counter was 
used for measuring the activity of 177Lu. 
3. Results and discussion 
3.1 NP coating characterization 
The sequence of construction of targeted NPs is shown in Fig. 1. It is similar to that reported 
elsewhere,11-12, 37 with several modifications. It involves: (1) mixture of OPSS-PEG-DOTA 
and OPSS-PEG-SVA; (2) attachment of these functional linkers to the Au NPs; (3) addition of 
PEG-SH to ensure complete coverage of the Au surface, followed by removal of excess linkers 
by centrifugation; (4) radiolabelling of the functionalised NPs with 177Lu, followed by removal 
of non-chelated 177Lu; (5) incubation with AB, followed by removal of non-conjugated AB. 
 
 Fig. 1. Sequence of construction of tagged 15 nm Au NPs. (1) Mixture of functional linkers, 
OPSS-PEG-DOTA and OPSS-PEG-SVA; (2) attachment of the functional linkers to the Au 
NPs; (3) addition of PEG-SH; (4) radiolabelling of the functionalised NPs with 177Lu; (5) 
incubation with AB. 
3.1.1 TEM 
Commercial Au NPs 15 nm in diameter showed a narrow size distribution and spherical 
morphology (Fig. 2A). After coating the NPs with OPSS-DOTA, OPSS-SVA-AB and PEG-
SH, no significant changes in size or size dispersion were observed (Fig. 2B), which indicates 
that none of the processes involved in the chemical modification of the NPs provoked their 
aggregation. Fig. 2C shows TEM images of HCT8 cells after exposure to OPSS-DOTA-, 
OPSS-SVA-AB- and PEG-SH-labelled NPs for 4 h. Targeted NPs can be found attached to the 
outer cell membrane, cytoplasm and structures within the cytoplasm, but not to the nucleus. 
This is generally the case for gold NPs unless they are specifically tagged for translocation into 
the nucleus.38 The absence of NPs inside the nucleus would preclude the use of therapies based 
on radionuclides emitting Auger electrons, which have a mean-free path of < 0.5 µm which is 
of the order of sub-cellular dimensions, and, thus, need to be within the nucleus to cause DNA 
damage. 
 
 
Fig. 2. TEM images of 15 nm gold NPs (A) and 15 nm gold NPs coated with OPSS-DOTA, 
OPSS-SVA-AB and PEG-SH (B), and HCT8 cells exposed to coated 15 nm Au NPs for 4 
hours (C). 
3.1.2 AF4-UV-MALS-ICPMS 
The working principle of AF4 is described in the Supporting Information and illustrated in Fig. 
S1. One advantage of AF4-UV-MALS-ICPMS is that the NP-organic system is characterized 
as an ensemble by the UV and MALS detectors, while additional online coupling of the AF4 
to ICPMS enables unambiguous element specific detection. However, surface plasmon 
resonance of gold NPs39-40 did not allow for accurate size determination by MALS. The Nova 
FFF software allows for calculation of size distribution based on anisotropic scattering. 
However, in the case of Au NPs, isotropic scattering (evenly scattering in all directions) is 
observed because of their singular optical features, making the calculation of nanoparticle size 
distribution using the FFF software unreliable. Consequently, diameters of the NP-organic 
shell system were evaluated by external calibration (Fig. S2) from the UV retention times of 
Au NPs standards of 5 nm, 15 nm, 50 nm and 60 nm (Fig. 3A). Retention times obtained for 
gold standards as obtained from fractograms monitored with the UV absorption detector are 
shown in Fig. 3A. ICPMS fractograms at m/z 197 (Fig. 3B) corroborated that all bands 
correspond to gold, and that artefacts are absent. MALS fractograms of the gold standards were 
acquired at 90° (Fig. S3 and S4). 5 nm gold NPs MALS signal was at the background level 
(Fig. S4), despite the intense bands found with the UV absorbance and ICPMS detectors. AF4-
UV-ICPMS measurements of gold NPs (15 nm diameter) with different organic coatings were 
also carried out (Fig. 3C and D), and the particle diameters were calculated as a function of the 
UV retention times using the calibration curve (Fig. S2). Diameters of coated Au NPs are 
shown in Table 1. Gold NPs coated only with OPSS-PEG-DOTA or OPSS-PEG-SVA showed 
similar diameters (42 and 41 nm, respectively), which is in good agreement with the length of 
the aliphatic chains. The diameter of OPSS-PEG-SVA-functionalised NPs increased slightly 
after AB binding but, interestingly, the OPSS-PEG-DOTA + OPSS-PEG-SVA-AB corona 
contracts after addition blocking the remaining NP surface with PEG-SH. This might be due to 
a shrinking of the pre-existing organic shell, probably due to H bonds and other types of dipole-
dipole interactions. Once completely coated (OPSS-PEG-DOTA/SVA-AB/PEG-SH), the 
gold-shell system showed diameters of 40 nm.  
 
 Fig. 3. (A) AF4 fractograms of 5 nm (black), 15 nm (purple), and 60 nm (green) commercial 
gold NPs, monitored with a UV detector at 525 nm. (B) AF4 fractograms of 5 nm (black), 15 
nm (purple), 50 nm (blue), and 60 nm (green) gold NPs standards, monitored with ICPMS at 
m/z 197. (C) AF4 fractograms monitored with a UV detector at 525 nm for 15 nm gold NPs 
labelled with OPSS-PEG-DOTA (a), OPSS-PEG-SVA (b), PEG-SH (c), OPSS-PEG-
SVA+AB (d), OPSS-PEG-DOTA-SVA+AB (e), OPSS-PEG-DOTA-SVA-PEG-SH (f), and 
OPSS-PEG-DOTA-SVA+AB-PEG-SH (g). (D) AF4 fractograms obtained for 15 nm gold NPs 
labelled with OPSS-PEG-DOTA (black), OPSS-PEG-SVA (red), PEG-SH (blue), OPSS-PEG-
SVA+AB (green), OPSS-PEG-DOTA-SVA (pink), OPSS-PEG-DOTA-SVA-PEG-SH 
(purple), and OPSS-PEG-DOTA-SVA+AB-PEG-SH (yellow), monitored with ICPMS at m/z 
197. 
 
Table 1. Average AF4 retention times, and resulting average diameter of Au NPs 15 nm in 
diameter with different coatings, obtained using a UV detector. 
NP coating 
Retention time 
(min) 
Diameter (nm) 
(a) OPSS-PEG-DOTA 23.2 42.7 ± 0.4 
(b) OPSS-PEG-SVA 22.7 41.3 ± 0.4 
(c) PEG-SH 17.3 26.3 ± 0.3 
(d) OPSS-PEG-SVA-AB 24.1 45.2 ± 0.4 
(e) OPSS-PEG-DOTA + 
OPSS-PEG-SVA-AB 
24.2 45.5 ± 0.4 
(f) OPSS-PEG-DOTA + 
OPSS-PEG-SVA + 
PEG-SH 
21.3 37.4 ± 0.4 
(g) OPSS-PEG-DOTA + 
OPSS-PEG-SVA-AB + 
PEG-SH 
22.1 39.7 ± 0.3 
  
3.1.3 Raman scattering 
Fig. 4 shows Raman spectra of Au NPs coated with OPSS-PEG-DOTA (Fig. 4A) and OPSS-
PEG-SVA-AB (Fig. 4B). Raman measurements demonstrated the NP labelling despite of the 
negligible SERS effect shown by 15 nm Au NPs.39-40 Fig. 4A shows the Raman spectra of 
OPSS-PEG-DOTA (black line) and OPSS-PEG-DOTA-coated Au NPs (red line). Both spectra 
show similar bands in the low-frequency region, with main bands at 365 cm-1, 584 cm-1 and 
718 cm-1, associated to (C-S-S), (S-S), ip(C-S), respectively.41-42 Significant differences 
may also be observed. Band at 265 cm-1, which only appear in the spectrum of OPSS-PEG-
DOTA-coated Au NPs can be ascribed to the (Au-S), which confirms NP labelling.43 Bands 
in the OPSS-PEG-DOTA spectrum between 840 cm-1 and 1000 cm-1 are associated to several 
ring modes of the pyridyl ring, and that at 775 cm-1 may be associated to normal mode with 
significant contribution of (C-N), which demonstrates that OPSS binding to Au is throughout 
a disulphide bridge. 
Labelling of OPSS-PEG with SVA and AB is shown in Figure 4B (red line). Band at 300 cm-
1 and 633 cmcorresponding to the (Au-S) and (C-S) from -CH2-S-S-, respectively,  
indicates the labelling with OPSS, which is in good agreement with the absence of bands 
related to pyridine (doublet at 1450/1480 cm-1, associated to monosubstituted pyridine 
semicircle stretching, non-bonded OPSS-PEG-SVA (blue line)). The labelling with AB is 
demonstrated by the absence of bands associated to succinimide, i.e., bands at 278 cm-1 
associated to in-plane (ip), (N-O), (C=O)ip, (C-N) and (C-O); at 364 cm-1 associated to 
(C-N) and (C-C) and at 537/580 cm-1 corresponding to (C=O), (blue line). Bands a 1240 
cm-1 and 1670 cm-1 are typical of amide III and amide I, respectively, from the -sheets 
structure of polypeptide backbone (with H-bonds between C=O and N-H groups from adjacent 
chains arranged either in parallel or anti-parallel modes,44 in good agreement with those found 
in the spectrum of the non-bonded antibody (black line). The intense band at 1000 cm-1 may 
be associated to the breathing mode of phenylalanine (Phe) aromatic ring. Also, the band at 
1550 cm-1 may be related to the W3 mode of tryptophan (Trp) (50% indole (C2=C3), 23% ( 
N1-C2) and 19% (C2-H) vibrations) and the weak band at 757 cm-1 may be associated to the 
W18 vibrational mode of Trp and Phe (cation-π interaction),45 demonstrating the successful 
labelling of Au NPs with AB via OPSS-PEG-SVA linker. 
 
 
Fig. 4. Raman spectra of (A) OPSS-PEG-DOTA (black line) and 15 nm Au NPs coated with 
OPSS-PEG-DOTA (red line) and (B) AB, Erbitux (black line), 15 nm Au NPs coated with 
OPSS-PEG-SVA-AB (red line) and OPSS-PEG-SVA (blue line). 
 
3.1.4 Force Distance Spectroscopy 
We have used AFM force-distance spectroscopy in order to give further insight into the NPs 
coating process by characterising the elastic properties of the modified NPs. Fig. 5 shows force-
distance curves obtained for the mica substrate (Fig. 5A), 15 nm gold NPs (Fig. 5B), 15 nm 
gold NPs coated with OPSS-PEG-DOTA (Fig. 5C), 15 nm gold NPs coated with OPSS-PEG-
SVA-AB (Fig. 5D), and with the complete coating, i.e., OPSS-PEG-DOTA + OPSS-PEG-
SVA-AB + PEG-SH (Fig. 5E). The corresponding contact-mode AFM images are shown in 
the inset. The force-distance profile in Fig. 5A is typical of an uncoated cantilever and a stiff 
hydrophilic surface, with a linear dependence of the force on the distance in both the approach 
and retract regions. The hysteresis found in the point of tip-surface attachment and detachment 
is related to strong adhesion forces due to a few monolayers of water on both the substrate 
surface and the cantilever. When covered with Au NPs, all samples showed the same slope in 
the linear region of the force-distance curves as that found on the mica substrate, as would be 
expected once the NPs layer has been penetrated. However, clear differences can be found in 
the attachment / detachment region, both when comparing between naked mica and the NPs-
covered substrate, and between NPs with different surface modifications. 
 
 
 
Fig. 5. AFM force-distance curves of the muscovite mica substrate (A), 15 nm diameter gold 
NPs (B), 15 nm gold NPs coated with DOTA (C), 15 nm gold NPs coated with SVA-AB (D), 
and 15 nm gold NPs coated with DOTA-SVA-AB-PEG-SH (E), in all cases deposited on the 
muscovite mica substrate. Black and red lines correspond to approach and retraction, 
respectively. Inset: corresponding contact-mode AFM images. 
 
 
In the case of naked Au NPs, the attachment region in the approach curve extends over a wider 
region than in the case of the mica substrate without NPs, indicating that additional energy 
(area integrated between the force-distance curve and the zero-force line) is necessary to break 
through the layer of Au NPs. Similarly, the retraction curve shows that, after detaching from 
the mica surface (initial vertical rise similar to that in Fig. 5A), additional energy is required to 
detach the tip form the layer of Au NPs. This pattern is typical of capillary phenomena 46 and, 
in this case, it may be attributed to isotropic adhesive forces between the naked NPs, which are 
probably covered by a few layers of water. This is in agreement with the corresponding contact-
mode AFM image (Fig. 5B, inset), where Au NPs appear as three-dimensional aggregates. 
Interestingly, in the case of gold NPs modified with OPSS-PEG-DOTA (Fig. 5C), the energy 
required to break through the layer of NPs (area within the black line around the point of 
contact), the adhesion force (minimum in the retraction curve), and the adhesion work are 
smaller than those obtained with both the clean mica substrate and with naked gold NPs. This 
must be due to the hydrophobic OPSS-PEG-DOTA layer preventing particle aggregation, in 
good agreement with the TEM images in Fig. 2B, and making it easier for the tip to break 
through the NP layer, as well as reducing the capillary attractive forces between the NPs and 
the tip. AFM contact-mode images (Fig. 5C, inset) support this assumption: DOTA-coated NPs 
display two-dimensional and nearly one-dimensional aggregates in a hexagonal distribution 
pattern matching the hexagonal symmetry of the mica substrate,47-49 an indication that NP-
substrate interactions are stronger than NP-NP interactions. 
Force-distance curves for gold NPs coated with OPSS-PEG-SVA-AB (Fig. 5D) suggest an 
increased cohesion energy between NPs, and an increased adhesion energy of the NPs with the 
AFM probe, which are now higher than in the case of naked Au NPs. AFM contact-mode 
images (Fig. 5D, inset) show that NPs arrange themselves in a fractal pattern. Together, these 
observations suggest the presence of directed, anisotropic, attractive interactions between the 
NPs, which dominate over NP-substrate interactions. Finally, in the case of gold NPs with the 
complete modification (OPSS-PEG-DOTA + OPSS-PEG-SVA-AB + PEG-SH, Fig. 5E), the 
behaviour is intermediate between that of OPSS-PEG-DOTA- and OPSS-PEG-SVA-AB-
coated NPs: the adhesion energy is intermediate, and contact-mode AFM images show an 
hexagonal arrangement of fractal patterns, suggesting the coexistence of anisotropic, 
directional interactions among NPs and similarly strong NP-substrate interactions. 
These results are indirect evidence of the success of the successive modification steps, as the 
addition of a new component on the coating layer clearly leads to a modification of the strength 
and directionality of the interactions between NPs, and between the NPs and the substrate. The 
reproducibility of both the force-distance curves and the calculated adhesion energy suggests 
that AFM force-distance measurements can be used as a suitable method for characterizing NP 
coating. 
 
3.2 Radiolabelling and cell uptake 
To demonstrate the success of the screening strategy developed here, the level of binding of 
the screened NPs to a panel of 5 cancer cells expressing EGFR at different levels was examined. 
This was carried out in the absence and presence of a large excess of AB (> 100x the amount 
conjugated to the [177Lu]-AB-NPs) which will compete with the targeting AB attached to the 
177Lu-NPs. Fig. 6A shows the expression of EGFR on each cell line. The order of expression 
of EGFR was MDA-MB-468 >> HCT8 > > SKBr3 > HCT116 > SW620. EGFR expression by 
SW620 cells was below the detection limit of the assay. The uptake of [177Lu]-AB-Au NPs 
showed a similar sequence (Fig. 6B). MDA-MB-468 cells exhibited much higher uptake 
corresponding with their high EGFR expression.  The presence of a large excess of AB 
decreased the binding of AB-targeted 177Lu-NPs by 95% (black) demonstrating that only about 
5% of the cell binding was due to non-targeting. This indicates that the cellular delivery of the 
cytotoxic radionuclide [177Lu] is dependent on EGFR expression, so potentially providing 
effective targeted anti-cancer therapy for tumour cells over-expressing EGFR.      
 
 
 
Fig. 6. EGFR-expression and 177Lu-AB-AuNP uptake by cancer cells determined using an 
ELISA assay (A) and uptake of 177Lu-AB-AuNPs determined by incubating cells with 177Lu-
AB-AuNPs alone (white) or in the presence of a large (100-fold excess of AB (black) to block 
the EGFR binding (non-receptor mediated cell binding – non-specific) (B). Units: EGFR 
expression – ng receptor/mg protein; 177Lu-AB-AuNP uptake - cpm/mg protein/106 cpm 
incubated activity 
 
 
4. Conclusions 
Targeted nuclear medicine has the potential to accelerate, simplify and reduce costs of the 
implementation of personalized medicine. The purpose of fabricating EGFR-targeted 177Lu-
AB-NPs is to deliver 177Lu specifically to cancer cells expressing EGFR at high levels. We 
have demonstrated that a combination of physico-chemical techniques allows to test whether 
the sequential functionalisation of 15 nm gold NPs with OPSS-PEG- linkers has been 
successful. TEM demonstrated that completely functionalised NPs showed good stability with 
no evidence of aggregation. The high sensitivity characteristic of AF4 coupled with UV-vis 
spectrophotometry, ICPMS and MALS detectors allowed us to calculate the diameter of the 
organic shell with a precision < 1 nm. After addition of PEG-SH, the shell tends to slightly 
contract because of dipole-dipole interactions and H-bonding with the OPSS-PEG-
DOTA/SVA, leading to a final diameter of 40 nm (including the gold core). Raman scattering 
allowed to confirm the presence of DOTA and PEG-SH on the surface of the modified NPs. 
Finally, both AFM images and force-distance curves proved efficient tools to identify 
successful chemical modification of the NPs, as the organic coating strongly influences the 
strength of NP-NP, NP-substrate and NP-tip interactions. Based on the high reproducibility of 
the results, the combination of AFM imaging and force distance spectroscopy is proposed as a 
reliable method for the characterization of the chemical and biological modification of metal 
NPs. Finally, we demonstrated that Au NPs assembled as described could be radiolabelled with 
high (> 75%) radiolabelling efficiency and that they provide effective targeted anti-cancer 
therapy for tumour cells over-expressing EGFR.      
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